Hengeler Mueller advises co-owners on sale of Aenova Group
06. August 2012
The co-owners of Aenova Group, Andreas and Peter Greither, have agreed together with majority owner Bridgepoint Capital on the complete sale of Aenova to private equity firm BC Partners.
Andreas and Peter Greither were the owners of Swiss Caps and Dragenopharm and sold majority stakes in both groups to Bridgepoint in 2005/07. Swiss Caps and Dragenopharm were then combined by Bridgepoint, Andreas and Peter Greither in 2008 into Aenova Group, a leading international provider of development and manufacturing services in the area of medicines and dietary supplements. Bridgepoint Capital is the majority shareholder of Aenova Group which is headquartered in Pähl (near Munich) and has around 1600 employees at eight sites in Europe and the United States.
Hengeler Mueller advised co-owners Andreas and Peter Greither on this transaction. The Hengeler Mueller team included partner Daniel Wiegand and counsel Attila Oldag (both M&A, Munich).